Latest Asx Continuous Disclosure News

The a2 Milk Company has responded to an ASX price query denying any undisclosed information behind recent share price moves, attributing the volatility to China’s latest birth statistics.

Neuren Pharmaceuticals has affirmed the material impact of Acadia’s projection that DAYBUE global net sales could reach approximately US$700 million by 2028, underpinning its royalty revenue outlook.

Ragusa Minerals has addressed recent unusual trading activity, confirming no undisclosed information while advancing its acquisition of a controlling stake in Pegasus Tel Inc. and the Purple Pansy Project in Arizona.

Auris Minerals Limited has been queried by the ASX following a sharp rise in its share price and trading volume, with the company denying any undisclosed information behind the surge.

Calix Limited has responded to an ASX price query following a notable rise in its share price and trading volume, confirming no undisclosed information and full compliance with listing rules.

Sprintex Limited has confirmed a significant €15.6 million purchase order from Mest Water, ensuring timely disclosure and compliance with ASX continuous disclosure rules. The company detailed its prior communications and trading halt strategy surrounding the announcement.

Coda Minerals has clarified that its recent share price and volume spike is driven by rising copper and silver prices, with no undisclosed company information influencing the market.

Dateline Resources has confirmed that recent drilling results at its Colosseum project are material information, becoming aware of their significance only after issuing a Cleansing Notice. The company assures compliance with ASX disclosure rules amid scrutiny over announcement timing.

Zoono Group Limited has responded to ASX queries confirming ongoing collaboration with OSY Group Limited, acknowledging delays in meeting sales targets but highlighting steady contract progress and future order potential.

Apiam Animal Health Limited shareholders are set to vote on a scheme of arrangement offering $0.87 cash per share or a mix of cash and unlisted scrip in a new holding company controlled by Adamantem Capital. The Independent Expert deems the cash offer fair and reasonable, while scrip options carry liquidity and minority risks.

Lion Rock Minerals has released previously withheld assay results from its Minta Project following an ASX price query, while highlighting a strategic shareholder's major financing announcement that may have influenced recent trading.

Tissue Repair Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with listing rules.